Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
123.2 EUR | -0.44% | +1.65% | +56.15% |
Apr. 11 | Berenberg Reiterates UCB's Purchase Rating, Raises PT | MT |
Apr. 11 | UCB : Berenberg, Buy, raises its price target | CF |
Sales 2024 * | 5.62B 6.03B | Sales 2025 * | 6.31B 6.77B | Capitalization | 23.74B 25.48B |
---|---|---|---|---|---|
Net income 2024 * | 466M 500M | Net income 2025 * | 880M 945M | EV / Sales 2024 * | 4.52 x |
Net Debt 2024 * | 1.63B 1.75B | Net Debt 2025 * | 802M 860M | EV / Sales 2025 * | 3.89 x |
P/E ratio 2024 * |
51
x | P/E ratio 2025 * |
25.9
x | Employees | 8,767 |
Yield 2024 * |
1.12% | Yield 2025 * |
1.16% | Free-Float | 61.44% |
Latest transcript on UCB
1 day | -0.73% | ||
1 week | +1.36% | ||
Current month | +7.39% | ||
1 month | +7.29% | ||
3 months | +40.72% | ||
6 months | +75.50% | ||
Current year | +55.70% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 65 | 11-05-31 | |
Sandrine Dufour
DFI | Director of Finance/CFO | 57 | 20-06-30 |
Chief Tech/Sci/R&D Officer | 63 | 17-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 16-04-27 | |
Dame Davies
BRD | Director/Board Member | 73 | 13-12-31 |
Director/Board Member | 69 | 10-04-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.88% | 2 M€ | +7.72% | ||
0.72% | 14 M€ | +5.66% | - | |
0.72% | 5 M€ | +10.09% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 123.2 | -0.44% | 61 825 |
24-04-25 | 125.1 | +3.56% | 349,967 |
24-04-24 | 120.8 | -0.78% | 179,471 |
24-04-23 | 121.8 | -0.20% | 184,505 |
24-04-22 | 122 | +0.66% | 311,888 |
Real-time Euronext Bruxelles, April 26, 2024 at 05:43 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.70% | 25.43B | |
-4.66% | 87.53B | |
+2.63% | 40.42B | |
-21.76% | 29.48B | |
-14.78% | 15.59B | |
-18.49% | 11.49B | |
-15.61% | 11.1B | |
-44.02% | 11.3B | |
+4.49% | 8.75B | |
-8.42% | 7.99B |
- Stock Market
- Equities
- UCB Stock